In this insightful interview, Richard Jaenisch, senior director of Education, Outreach, and Digital Experience at Open ...

Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, ...

France’s Saint‑Julien site adds a bioprocess development suite for upstream/downstream scale-up of recombinant proteins, including complex mAbs and ADCs, and doubles bioconjugation capacity. Rodano, ...

The pharmaceutical industry is navigating one of its most disruptive periods in recent memory, according to Anthony Lakavage, ...

Tony Lakavage, executive vice president and head of Global External Affairs at the US Pharmacopeia (USP), outlines the key ...

FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...

Global External Affairs, US Pharmacopeia (USP), discusses drug supply chain vulnerabilities tied to China dependence, urging ...

Denis Beckford Vera, head of Radiopharmacology, Champion Oncology advocates clinically relevant PDX models to bridge ...

Denis Beckford Vera, head of Radiopharmacology, Champion Oncology explains how patient-derived xenografts improve drug ...

SGD Pharma and Prince launch sterile Type I glass nasal vials for the US market, targeting complex chronic conditions like ...

IRA revisions now exempt multi-indication orphan drugs from price negotiations, improving lifecycle economics and encouraging ...

DCAT Week 2026, New York draws together a pharmaceutical supply chain sector navigating familiar pressures: drug shortages, ...